| 发明名称 |
Pharmaceutical formulations containing an SGLT2 inhibitor |
| 摘要 |
Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrate and a pharmaceutical acceptable carrier therefor, which formulation is designed for immediate release.
|
| 申请公布号 |
US8361972(B2) |
申请公布日期 |
2013.01.29 |
| 申请号 |
US201213529463 |
申请日期 |
2012.06.21 |
| 申请人 |
BRISTOL MYERS-SQUIBB COMPANY;BINDRA DILBIR S.;DALI MANDAR V.;PARAB PRAKASH V.;PATEL JATIN M.;TAO LI;TEJWANI RAVINDRA W.;VATSARAJ NIPA;WU YONGMEI |
发明人 |
BINDRA DILBIR S.;DALI MANDAR V.;PARAB PRAKASH V.;PATEL JATIN M.;TAO LI;TEJWANI RAVINDRA W.;VATSARAJ NIPA;WU YONGMEI |
| 分类号 |
A61K9/48;A61K9/30;A61K31/70;A61P3/00;A61P9/00 |
主分类号 |
A61K9/48 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
